Internal Server Error

About InterWest Partners

InterWest Partners is a venture capital firm founded in 1979. It is primarily based out of Los Altos, United States. As of Oct 2021, InterWest Partners has invested in 257 companies. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Life Sciences and High Tech. Most recently it participated in the $***** Series C round of GoCheck Kids Overall, InterWest Partners portfolio has seen 1 unicorn, 32 IPOs and 143 acquisitions including key companies like Workday, Jazz Pharmaceuticals and The RealReal. A lot of funds co-invest with InterWest Partners, with names like New Enterprise Associates sharing a substantial percentage of its portfolio. InterWest Partners has team of 2 people including 2 partners.
Key Metrics
Team Members
Portfolio Count
Portfolio Locations
Rounds of Entry
Series B, Series A & 9 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns

InterWest Partners' List of Top Investments

InterWest Partners has a portfolio of 257 companies, one of which is a Unicorn. Their most notable investments are in Integrated Diagnostics and Splice Machine.Their portfolio spans across United States, United Kingdom, Canada and 8 more locations. They have invested in Enterprise Applications, Life Sciences, High Tech and 24 other sectors, across stages such as Series B, Series A  and 9 more. Here is the list of top investments by InterWest Partners:
Developer of cloud software for human resources finance and operations. The software provides tools for managing workforce planning, payroll, financial accounting, and contract lifecycle management. The platform integrates data across business functions to assist with organizational management and administrative tasks. It includes artificial intelligence capabilities designed to automate workflows and support decision-making processes for enterprise management.

Key facts about Workday

Cloud-based collaborative design platform. It enables users to create various digital content, including social media posts, presentations, and videos, through its drag-and-drop editor. The platform provides access to thousands of templates, photos, and fonts, and offers AI-powered tools for users to enhance design abilities. It allows users to edit images for presentations, invitations, posters, flyers, business cards, and more. The platform offers pre-designed templates and effects. It also provides a stock library of photographs, illustrations, and images.

Key facts about Canva

Developer of novel biopharmaceutical medicines for unmet medical needs. It focuses on developing and delivering life-changing medications to patients with limited or no treatment options. The company's pipeline includes various therapeutic areas, and it supports its medicines with robust clinical trial programs and patient support resources. Research efforts prioritize patient needs, driving advancements in understanding and treating specific conditions. The company also engages in corporate giving and sustainability initiatives.

Key facts about Jazz Pharmaceuticals

  • Founded Year: 2003
  • Location: Dublin (Ireland)
  • Annual Revenue: $500M - $1B as on Dec 31, 2020
  • Stage: Public
  • Total Funding till date: $265M
  • Employee Count: 3,624 as on May 31, 2026
  • Investors: Adams Street Partners, Thoma Bravo and 14 Others
  • Latest Funding Round: Post IPO, Jul 07, 2009, $*****
  • Highlight: Public
Online consignment-based marketplace for luxury fashion. The product catalog includes apparel for men & women of used products. It also offers jewelry and fashion accessories.

Key facts about The RealReal

  • Founded Year: 2011
  • Location: Tiburon (United States)
  • Stage: Public
  • Total Funding till date: $288M
  • Employee Count: 2,631 as on Jun 30, 2026
  • Investors: HTIF, OGGI Equity and 37 Others
  • Latest Funding Round: Post IPO, Mar 04, 2021, $*****
  • Highlight: Public
Mobile networking platform for medical professionals. Physicians can connect with other healthcare professionals, collaborate on patient treatment, grow their practices, and discover new career opportunities. Also allows hospitals to find doctors and recruiters. It offers information on residency training programs in collaboration.

Key facts about Doximity

  • Founded Year: 2011
  • Location: San Mateo (United States)
  • Annual Revenue: $500M - $1B as on Mar 31, 2025
  • Stage: Public
  • Total Funding till date: $81.9M
  • Employee Count: 912 as on Jun 30, 2026
  • Investors: HTIF, T. Rowe Price and 8 Others
  • Latest Funding Round: Series C, Apr 29, 2014, $*****
  • Highlight: Public

InterWest Partners' Investments by Stage

InterWest Partners has made 58 investments in Series B stage with an average round size of $21.2M, 48 investments in Series A stage with an average round size of $15.9M and 25 investments in Series C stage with an average round size of $25.4M.
Here are InterWest Partners' investments by stage:
Stage of entry
No. of Investments
Series B
58
Series A
48
Series C
25
Series D
22
Seed
16
Others
13
Breakdown of InterWest Partners' investments by stage of entrySeries B (58)Series A (48)
Note: We have considered here, only first round of investments

InterWest Partners' Investments by Sector

InterWest Partners has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, Enterprise Infrastructure, Consumer and Semiconductors. Notably, it has invested in 203 Tech companies, 181 Enterprise (B2B) companies, 110 Software companies and at least 49 companies focusing on Saas.
Here are InterWest Partners' investments by sector:
Sector
No. of Investments
Life Sciences
74
Enterprise Applications
65
Enterprise Infrastructure
18
Consumer
15
Semiconductors
15
Others
96
Breakdown of InterWest Partners' investments by sectorsLife Sciences (74)Enterprise Applic... (65)
Note: We have considered here, only first round of investments

InterWest Partners' Investments by Geography

InterWest Partners has made most investments in United States (169), followed by United Kingdom where it has made 4 investments.
Here are InterWest Partners' investments by geography:
Country
No. of Investments
United States
169
United Kingdom
4
Germany
3
Australia
1
Canada
1
Others
4
Breakdown of InterWest Partners' investments by countriesUnited States (169)United Kingdom (4)
Note: We have considered here, only first round of investments

InterWest Partners' recent investments

InterWest Partners has not made any investment in 2026 so far.
Here are the most recent investments by InterWest Partners:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Oct 20, 2021
United States
Series C
1540
Nov 13, 2019
United States
Series C
4089
Jul 11, 2019
United States
Series D
8572
  [+5]
May 01, 2019
United States
Series F
1165
Jan 02, 2019
United States
Series F
1800
  [+7]

Unicorns in InterWest Partners' Portfolio

InterWest Partners has 1 unicorn in its portfolio - Intarcia. The most recent unicorn in their portfolio is Intarcia which became a unicorn in 2014, 13 years after InterWest Partners first invested in it.
Here is a list of unicorns in InterWest Partners' portfolio:
Tracxn Score
Company
Short Description
Founded year
Sector
Location
Company Stage
First Investment/ Acquisition Details
47
Provider of osmotic pump for subcutaneous drug delivery
1995
Boston
Series J
xdiuzwq

IPOs and Publicly Listed companies in InterWest Partners' Portfolio

32 of InterWest Partners' portfolio companies have become public. Braze got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Nov 2021 at marketcap of $5.87B and CVRx got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $126M.
Here are InterWest Partners' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Nov 17, 2021
Oct 02, 2014
Series B
5177
Jun 30, 2021
May 11, 2006
Series C
2162
Jun 24, 2021
Mar 16, 2011
Series A
9139
Apr 22, 2021
2005
Series A
4324
Dec 09, 2020
Sep 01, 2016
Series D
9041

Acquired companies in InterWest Partners' Portfolio

143 companies from InterWest Partners' portfolio have been acquired. The most recent acquisition was KalVista in Apr 2026 by Chiesi Pharmaceuticals for $*****.
Here are InterWest Partners' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Apr 29, 2026
-
-
8469
Dec 29, 2025
Aug 27, 2007
Series D
4335
Dec 24, 2025
Sep 26, 2000
Series C
8799
Nov 14, 2025
Jun 16, 2014
Series A
9358
Mar 05, 2025
-
-
8530

Team profile of InterWest Partners

InterWest Partners has a team of 2 members including 2 Partners located in United States. InterWest Partners' team does not sit on the board of any company as of now.

Co-investors of InterWest Partners

Over the past 29 years, 887 investors have co-invested in InterWest Partners's portfolio companies. This includes funds and angels.

  • Invested before InterWest PartnersTrinity Ventures, Domain Associates and 175 others have invested in rounds before InterWest Partners. There are 4 companies where Trinity Ventures has invested before InterWest Partners and 4 companies where Domain Associates has invested before InterWest Partners.
  • Top Co-investors of InterWest Partners315 investors entered a company along with InterWest Partners. These include investors like New Enterprise Associates (10 companies).
  • Invested after InterWest PartnersA total of 395 investors have invested in InterWest Partners's portfolio after their investments. Top Investors include HHS (6 companies), Venrock (5 companies) and RA Capital Management (5 companies).

Recent News related to InterWest Partners

View all news related to InterWest Partners

FAQs about InterWest Partners

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford